A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
An orchestra made up entirely of robots, will make its public premier on Wednesday as part of Manchester's Science Festival.
An experimental autism therapy being trailed in Manchester has had a record level of success in reducing core symptoms of the condition.
A man who was shot dead in Aigburth on Monday night has been named as Blake Brown, 30.